Amicus Therapeutics
FOLD
FOLD
186 hedge funds and large institutions have $2.99B invested in Amicus Therapeutics in 2017 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 72 increasing their positions, 38 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% more call options, than puts
Call options by funds: $81.8M | Put options by funds: $75.4M
1.31% less ownership
Funds ownership: 121.86% → 120.55% (-1.3%)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
186
Holding in Top 10
7
Calls
$81.8M
Puts
$75.4M
Top Buyers
| 1 | +$79.6M | |
| 2 | +$62.8M | |
| 3 | +$40.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$34.1M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$31.4M |
Top Sellers
| 1 | -$32M | |
| 2 | -$28.3M | |
| 3 | -$19M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$16.2M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$15.6M |